SHREE GANESH REMEDIES
|
SHREE GANESH REMEDIES Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹8.97 Cr | ₹8.97 Cr |
Equity - Authorised | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹10.00 Cr | ₹10.00 Cr |
Equity - Issued | ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹8.97 Cr | ₹8.97 Cr |
Equity Paid Up | ₹13 Cr | ₹12 Cr | ₹10 Cr | ₹8.97 Cr | ₹8.97 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹76 Cr | ₹50 Cr | ₹40 Cr | ₹33 Cr | ₹25 Cr |
Securities Premium | ₹15 Cr | ₹5.01 Cr | ₹7.01 Cr | ₹7.01 Cr | ₹7.01 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹61 Cr | ₹45 Cr | ₹33 Cr | ₹26 Cr | ₹18 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹-0.13 Cr | ₹-0.16 Cr | ₹-0.16 Cr | ₹-0.16 Cr | ₹-0.16 Cr |
Reserve excluding Revaluation Reserve | ₹76 Cr | ₹50 Cr | ₹40 Cr | ₹33 Cr | ₹25 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹89 Cr | ₹62 Cr | ₹50 Cr | ₹42 Cr | ₹34 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹31 Cr | - | - | ₹0.04 Cr | ₹0.24 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹32 Cr | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-1.01 Cr | - | - | ₹0.04 Cr | ₹0.24 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-0.09 Cr | ₹0.20 Cr | ₹0.24 Cr | ₹0.28 Cr | ₹0.33 Cr |
Deferred Tax Assets | ₹0.09 Cr | - | - | - | - |
Deferred Tax Liability | - | ₹0.20 Cr | ₹0.24 Cr | ₹0.28 Cr | ₹0.33 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.22 Cr | ₹0.20 Cr | ₹0.17 Cr | ₹0.18 Cr | ₹0.16 Cr |
Total Non-Current Liabilities | ₹31 Cr | ₹0.40 Cr | ₹0.41 Cr | ₹0.50 Cr | ₹0.73 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹15 Cr | ₹9.47 Cr | ₹6.21 Cr | ₹3.86 Cr | ₹3.90 Cr |
Sundry Creditors | ₹15 Cr | ₹9.47 Cr | ₹6.21 Cr | ₹3.86 Cr | ₹3.90 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹1.01 Cr | - | ₹0.04 Cr | ₹0.20 Cr | ₹0.18 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹1.01 Cr | - | ₹0.04 Cr | ₹0.20 Cr | ₹0.18 Cr |
Short Term Borrowings | ₹1.57 Cr | - | ₹0.17 Cr | ₹2.07 Cr | ₹0.33 Cr |
Secured ST Loans repayable on Demands | - | - | ₹0.17 Cr | ₹2.07 Cr | ₹0.33 Cr |
Working Capital Loans- Sec | - | - | ₹0.17 Cr | ₹2.07 Cr | ₹0.33 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹1.57 Cr | - | ₹-0.17 Cr | ₹-2.07 Cr | ₹-0.33 Cr |
Short Term Provisions | ₹6.63 Cr | ₹5.57 Cr | ₹3.77 Cr | ₹3.54 Cr | ₹2.39 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹5.85 Cr | ₹4.65 Cr | ₹3.23 Cr | ₹3.18 Cr | ₹2.19 Cr |
Provision for post retirement benefits | - | - | ₹0.38 Cr | ₹0.22 Cr | ₹0.13 Cr |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.78 Cr | ₹0.92 Cr | ₹0.16 Cr | ₹0.15 Cr | ₹0.06 Cr |
Total Current Liabilities | ₹24 Cr | ₹15 Cr | ₹10 Cr | ₹9.67 Cr | ₹6.79 Cr |
Total Liabilities | ₹144 Cr | ₹77 Cr | ₹61 Cr | ₹52 Cr | ₹41 Cr |
ASSETS | |||||
Gross Block | ₹55 Cr | ₹42 Cr | ₹30 Cr | ₹25 Cr | ₹21 Cr |
Less: Accumulated Depreciation | ₹19 Cr | ₹15 Cr | ₹11 Cr | ₹8.85 Cr | ₹6.56 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹36 Cr | ₹27 Cr | ₹19 Cr | ₹16 Cr | ₹14 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹42 Cr | ₹3.09 Cr | ₹2.05 Cr | - | - |
Non Current Investments | ₹0.08 Cr | ₹0.08 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.05 Cr |
Long Term Investment | ₹0.08 Cr | ₹0.08 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.05 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.08 Cr | ₹0.08 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.05 Cr |
Long Term Loans & Advances | ₹0.96 Cr | ₹0.61 Cr | ₹0.60 Cr | ₹0.93 Cr | ₹0.72 Cr |
Other Non Current Assets | ₹0.40 Cr | ₹1.13 Cr | ₹1.03 Cr | ₹0.20 Cr | ₹0.27 Cr |
Total Non-Current Assets | ₹79 Cr | ₹32 Cr | ₹23 Cr | ₹17 Cr | ₹16 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | ₹3.12 Cr | ₹7.05 Cr | ₹4.00 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | ₹3.12 Cr | ₹7.05 Cr | ₹4.00 Cr |
Inventories | ₹18 Cr | ₹14 Cr | ₹13 Cr | ₹5.50 Cr | ₹6.51 Cr |
Raw Materials | ₹8.52 Cr | ₹4.65 Cr | ₹4.15 Cr | ₹0.91 Cr | ₹1.89 Cr |
Work-in Progress | ₹3.09 Cr | ₹4.42 Cr | ₹1.92 Cr | - | ₹0.45 Cr |
Finished Goods | ₹6.44 Cr | ₹4.46 Cr | ₹6.56 Cr | ₹4.52 Cr | ₹4.15 Cr |
Packing Materials | ₹0.12 Cr | ₹0.11 Cr | ₹0.08 Cr | ₹0.08 Cr | ₹0.02 Cr |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹28 Cr | ₹18 Cr | ₹13 Cr | ₹17 Cr | ₹9.72 Cr |
Debtors more than Six months | ₹0.03 Cr | ₹0.07 Cr | ₹0.02 Cr | - | - |
Debtors Others | ₹28 Cr | ₹18 Cr | ₹13 Cr | ₹17 Cr | ₹9.72 Cr |
Cash and Bank | ₹11 Cr | ₹3.88 Cr | ₹3.47 Cr | ₹1.75 Cr | ₹1.00 Cr |
Cash in hand | ₹0.01 Cr | ₹0.02 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.03 Cr |
Balances at Bank | ₹11 Cr | ₹3.87 Cr | ₹3.45 Cr | ₹1.74 Cr | ₹0.96 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | - | - | - | - | - |
Short Term Loans and Advances | ₹7.04 Cr | ₹9.00 Cr | ₹5.36 Cr | ₹3.88 Cr | ₹4.58 Cr |
Advances recoverable in cash or in kind | - | - | - | - | - |
Advance income tax and TDS | ₹5.03 Cr | ₹3.93 Cr | ₹3.01 Cr | ₹3.01 Cr | ₹2.07 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | ₹0.02 Cr | ₹0.15 Cr | ₹0.11 Cr | ₹0.01 Cr | ₹0.05 Cr |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹1.99 Cr | ₹4.92 Cr | ₹2.24 Cr | ₹0.86 Cr | ₹2.46 Cr |
Total Current Assets | ₹64 Cr | ₹45 Cr | ₹38 Cr | ₹35 Cr | ₹26 Cr |
Net Current Assets (Including Current Investments) | ₹41 Cr | ₹30 Cr | ₹28 Cr | ₹25 Cr | ₹19 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹144 Cr | ₹77 Cr | ₹61 Cr | ₹52 Cr | ₹41 Cr |
Contingent Liabilities | ₹4.18 Cr | - | - | - | - |
Total Debt | ₹34 Cr | - | ₹0.22 Cr | ₹2.31 Cr | ₹0.75 Cr |
Book Value | - | 51.28 | 49.97 | 46.92 | 37.70 |
Adjusted Book Value | 71.09 | 50.92 | 41.35 | 34.81 | 27.97 |
Compare Balance Sheet of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹780.5 Cr | -2.2% | -9.1% | 90% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,035.0 Cr | -3.7% | -1.4% | 26% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | -2.2% |
-9.1% |
90% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses